Theranib Inc.
PrivateLast Round
Grant
Apr 1, 2026
Total Funding Raised
$2.78M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Theranib Inc. is a biotechnology company that develops precision cancer therapies targeting the ALDH1A3 enzyme to combat metastasis and therapy resistance in solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theranib Inc. Comparables
Compare Theranib Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced BioDesign | 80% | |
| Pacylex Pharmaceuticals | 70% | |
| Kayothera | 68% | |
Theranib Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2026 | ||||
| Accelerator | Sep 17, 2025 |
Theranib Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Innovacorp | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 494% MoM.
- May 11, 2026
Monthly visitors grew 474% MoM, reaching 1.9K.
Theranib Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Theranib Inc.'s valuation, stock price, and market status.